Medtronic plc, headquartered in Dublin, is a listed company in the field of medical technology. The company is known for its pacemakers, implantable cardioverter defibrillators, heart valves, insulin pumps, aortic stent grafts, coronary stents and neurostimulators. Medtronic manufactures more than half of all pacemakers implanted worldwide.
According to Medtronic's latest financial reports the company's current revenue (TTM ) is โฌ29.21 Billion. In 2024 the company made a revenue of โฌ31.90 Billion an increase over the revenue in the year 2023 that were of โฌ29.23 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2025 (TTM) | โฌ31.04 B | -2.69% |
2024 | โฌ31.90 B | 9.12% |
2023 | โฌ29.23 B | 1.92% |
2022 | โฌ28.68 B | 2.21% |
2021 | โฌ28.06 B | 23.62% |
2020 | โฌ22.70 B | -18.12% |
2019 | โฌ27.72 B | 3.82% |
2018 | โฌ26.70 B | 7.81% |
2017 | โฌ24.77 B | -11.25% |
2016 | โฌ27.91 B | 6.83% |
2015 | โฌ26.12 B | 81.37% |
2014 | โฌ14.40 B | 17.73% |
2013 | โฌ12.23 B | -1.46% |
2012 | โฌ12.41 B | -0.34% |
2011 | โฌ12.46 B | 5.37% |
2010 | โฌ11.82 B | 9.65% |
2009 | โฌ10.78 B | 3.05% |
2008 | โฌ10.46 B | 18.12% |
2007 | โฌ8.85 B | -3.28% |
2006 | โฌ9.16 B | -1.38% |
2005 | โฌ9.28 B | 26.73% |
2004 | โฌ7.32 B | 7.68% |
2003 | โฌ6.80 B | -2.65% |
2002 | โฌ6.99 B | 0.61% |
2001 | โฌ6.94 B | 19.77% |
2000 | โฌ5.80 B | 24.93% |
1999 | โฌ4.64 B | 47.92% |
1998 | โฌ3.13 B | 34.05% |
1997 | โฌ2.34 B | 16.11% |
1996 | โฌ2.01 B |